These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28215180)

  • 21. The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.
    Babic N; Valjevac A; Zaciragic A; Avdagic N; Zukic S; Hasic S
    Med Arch; 2019 Jun; 73(3):163-168. PubMed ID: 31404127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage.
    Vázquez LA; Rodríguez Á; Salvador J; Ascaso JF; Petto H; Reviriego J
    BMC Cardiovasc Disord; 2014 Nov; 14():153. PubMed ID: 25361574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease mortality in type II diabetes mellitus: glycemic and renal function control.
    Borghi C; Ventura F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e13-e15. PubMed ID: 29538138
    [No Abstract]   [Full Text] [Related]  

  • 24. Glycaemic indices and non-traditional biochemical cardiovascular disease markers in a diabetic population in Nigeria.
    Ogbera OA; Azenabor A
    J Coll Physicians Surg Pak; 2011 Aug; 21(8):455-9. PubMed ID: 21798129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
    Menon V; Kumar A; Patel DR; John JS; Wolski KE; McErlean E; Riesmeyer JS; Weerakkody G; Ruotolo G; Cremer PC; Nicholls SJ; Lincoff AM; Nissen SE
    J Am Heart Assoc; 2020 Jan; 9(1):e014328. PubMed ID: 31852422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention.
    Nusca A; Tuccinardi D; Proscia C; Melfi R; Manfrini S; Nicolucci A; Ceriello A; Pozzilli P; Ussia GP; Grigioni F; Di Sciascio G
    Cardiovasc Diabetol; 2019 Nov; 18(1):147. PubMed ID: 31706305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low circulating vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c.
    Zagami RM; Di Pino A; Urbano F; Piro S; Purrello F; Rabuazzo AM
    Atherosclerosis; 2015 Dec; 243(2):395-401. PubMed ID: 26520892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between Cystatin C and retinopathy of type-two diabetes mellitus patients.
    Qian C; Wan GM; Yan PS; Wang WZ; Liang SZ; Dong Y
    J Biol Regul Homeost Agents; 2017; 31(1):99-103. PubMed ID: 28337877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
    Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between brachial-ankle pulse wave velocity and glycemic control of type 2 diabetes mellitus patients in Beijing community population].
    Sun KX; Liu ZK; Cao YY; Juan J; Xiang X; Yang C; Huang SP; Liu XF; Li N; Tang X; Li J; Wu T; Chen DF; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 47(3):431-6. PubMed ID: 26080871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease.
    Poreba M; Rostoff P; Siniarski A; Mostowik M; Golebiowska-Wiatrak R; Nessler J; Undas A; Gajos G
    Cardiovasc Diabetol; 2018 Feb; 17(1):29. PubMed ID: 29452596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary glycemic index and glycemic load are associated with metabolic control in type 2 diabetes: The CAPRI experience.
    Esposito K; Maiorino MI; Di Palo C; Giugliano D;
    Metab Syndr Relat Disord; 2010 Jun; 8(3):255-61. PubMed ID: 20158448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycaemic control among patients with type 2 diabetes followed in a rural African primary care setting - A reality check in the Democratic Republic of Congo.
    Blum J; Chaney M; Mudji J; Mfungwa JK; Rice T; Labhardt ND
    Prim Care Diabetes; 2020 Apr; 14(2):139-146. PubMed ID: 31455548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Improved Glycemic Control on Cardiac Function in Type 2 Diabetes Mellitus.
    Leung M; Wong VW; Hudson M; Leung DY
    Circ Cardiovasc Imaging; 2016 Mar; 9(3):e003643. PubMed ID: 26962125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensive lifestyle intervention is particularly advantageous in poorly controlled type 2 diabetes.
    Sbroma Tomaro E; Pippi R; Reginato E; Aiello C; Buratta L; Mazzeschi C; Perrone C; Ranucci C; Tirimagni A; Russo A; Fatone C; Fanelli C; De Feo P
    Nutr Metab Cardiovasc Dis; 2017 Aug; 27(8):688-694. PubMed ID: 28735815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical Activity Indicators, Metabolic Biomarkers, and Comorbidity in Type 2 Diabetes.
    Akinci B; Yeldan I; Celik S; Satman I
    Res Q Exerc Sport; 2019 Dec; 90(4):690-698. PubMed ID: 31479402
    [No Abstract]   [Full Text] [Related]  

  • 38. Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report.
    Matsutani D; Sakamoto M; Iuchi H; Minato S; Suzuki H; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
    Cardiovasc Diabetol; 2018 Mar; 17(1):36. PubMed ID: 29514695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND.
    Konig M; Riddle MC; Colhoun HM; Branch KR; Atisso CM; Lakshmanan MC; Mody R; Raha S; Gerstein HC
    Cardiovasc Diabetol; 2021 Sep; 20(1):194. PubMed ID: 34563178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of diabetes education and short message service reminders on metabolic control and disease management in patients with type 2 diabetes mellitus.
    Güner TA; Coşansu G
    Prim Care Diabetes; 2020 Oct; 14(5):482-487. PubMed ID: 32471770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.